BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25818517)

  • 1. Population pharmacokinetics of cyclosporine in hematopoietic stem cell transplant patients: consideration of genetic polymorphisms.
    Kim MG; Kim IW; Choi B; Han N; Yun HY; Park S; Oh JM
    Ann Pharmacother; 2015 Jun; 49(6):622-30. PubMed ID: 25818517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patients.
    Xue L; Zhang WW; Ding XL; Zhang JJ; Bao JA; Miao LY
    Am J Med Sci; 2014 Dec; 348(6):448-54. PubMed ID: 25247760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation.
    Li TF; Hu L; Ma XL; Huang L; Liu XM; Luo XX; Feng WY; Wu CF
    Acta Pharmacol Sin; 2019 Dec; 40(12):1603-1610. PubMed ID: 31341257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.
    Wilhelm AJ; de Graaf P; Veldkamp AI; Janssen JJ; Huijgens PC; Swart EL
    Br J Clin Pharmacol; 2012 Apr; 73(4):553-63. PubMed ID: 21988410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCB1 C3435T genetic polymorphism on population pharmacokinetics of methotrexate after hematopoietic stem cell transplantation in Korean patients: a prospective analysis.
    Kim IW; Yun HY; Choi B; Han N; Park SY; Lee ES; Oh JM
    Clin Ther; 2012 Aug; 34(8):1816-26. PubMed ID: 22796246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP3A5 polymorphism effect on cyclosporine pharmacokinetics in living donor renal transplant recipients: analysis by population pharmacokinetics.
    Song J; Kim MG; Choi B; Han NY; Yun HY; Yoon JH; Oh JM
    Ann Pharmacother; 2012 Sep; 46(9):1141-51. PubMed ID: 22947591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics and Bayesian estimation of cyclosporine in a Tunisian population of hematopoietic stem cell transplant recipient.
    Eljebari H; Gaies E; Fradj NB; Jebabli N; Salouage I; Trabelsi S; Lakhal M; Klouz A
    Eur J Clin Pharmacol; 2012 Nov; 68(11):1517-24. PubMed ID: 22527344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantation.
    Jacobson PA; Ng J; Green KG; Rogosheske J; Brundage R
    Biol Blood Marrow Transplant; 2003 May; 9(5):304-11. PubMed ID: 12766880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of ciclosporin in allogeneic hematopoietic stem cell transplant recipients: C-reactive protein as a novel covariate for clearance.
    Ling J; Yang XP; Dong LL; Jiang Y; Zou SL; Hu N; Chen R
    J Clin Pharm Ther; 2022 Apr; 47(4):483-492. PubMed ID: 34779003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
    Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
    Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of cyclosporine A based on NONMEM in Chinese allogeneic hematopoietic stem cell transplantation recipients.
    Zhou H; Gao Y; Cheng XL; Li ZD
    Eur J Drug Metab Pharmacokinet; 2012 Dec; 37(4):271-8. PubMed ID: 22446981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes.
    Hesselink DA; van Gelder T; van Schaik RH; Balk AH; van der Heiden IP; van Dam T; van der Werf M; Weimar W; Mathot RA
    Clin Pharmacol Ther; 2004 Dec; 76(6):545-56. PubMed ID: 15592326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic study of cyclosporine in the hematopoietic stem cell transplant recipients.
    Zhou Y; Sheng XY; Xu JY; Bi SS; Lu W; Cui YM
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):568-75. PubMed ID: 23611568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients.
    Santoro A; Felipe CR; Tedesco-Silva H; Medina-Pestana JO; Struchiner CJ; Ojopi EB; Suarez-Kurtz G
    Pharmacogenomics; 2011 Sep; 12(9):1293-303. PubMed ID: 21806386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic study of cyclosporine based on NONMEM in Chinese liver transplant recipients.
    Sun B; Li XY; Gao JW; Rui JZ; Guo YK; Peng ZH; Liu GL
    Ther Drug Monit; 2010 Dec; 32(6):715-22. PubMed ID: 21068646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A drug transporter for all ages? ABCB1 and the developmental pharmacogenetics of cyclosporine.
    Hesselink DA; van Schaik RH; Nauta J; van Gelder T
    Pharmacogenomics; 2008 Jun; 9(6):783-9. PubMed ID: 18518855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state pharmacokinetics of mycophenolic acid in renal transplant patients: exploratory analysis of the effects of cyclosporine, recipients' and donors' ABCC2 gene variants, and their interactions.
    Božina N; Lalić Z; Nađ-Škegro S; Borić-Bilušić A; Božina T; Kaštelan Ž; Trkulja V
    Eur J Clin Pharmacol; 2017 Sep; 73(9):1129-1140. PubMed ID: 28624888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics analysis of cyclophosphamide with genetic effects in patients undergoing hematopoietic stem cell transplantation.
    Kim IW; Yun HY; Choi B; Han N; Kim MG; Park S; Oh JM
    Eur J Clin Pharmacol; 2013 Aug; 69(8):1543-51. PubMed ID: 23588565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of cyclosporine in clinical renal transplant patients.
    Wu KH; Cui YM; Guo JF; Zhou Y; Zhai SD; Cui FD; Lu W
    Drug Metab Dispos; 2005 Sep; 33(9):1268-75. PubMed ID: 15932953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetic modeling of oral cyclosporin using NONMEM: comparison of absorption pharmacokinetic models and design of a Bayesian estimator.
    Rousseau A; Léger F; Le Meur Y; Saint-Marcoux F; Paintaud G; Buchler M; Marquet P
    Ther Drug Monit; 2004 Feb; 26(1):23-30. PubMed ID: 14749545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.